Prevention of Chronic Experimental Colitis Induced by Dextran Sulphate Sodium (DSS) in Mice Treated with FR91

<table>Image analysis of the mean value of colorectal damage area marked by immunoreactivity in mice groups. Group 5 showed a significantly difference <svg height="13.6375" id="M22" style="vertical-align:-2.21957pt" version="1.1" viewbox="0 0 66.550003 13.6375" width="66.550003" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,13.6375)">
<g transform="translate(72,-61.09)">
<text transform="matrix(1,0,0,-1,-71.95,63.35)">
<tspan style="font-size: 12.50px; " x="0" y="0">(</tspan>
<tspan style="font-size: 12.50px; " x="4.1634989" y="0">𝑃</tspan>
<tspan style="font-size: 12.50px; " x="15.053612" y="0">&lt;</tspan>
<tspan style="font-size: 12.50px; " x="27.094002" y="0">0</tspan>
<tspan style="font-size: 12.50px; " x="33.345501" y="0">.</tspan>
<tspan style="font-size: 12.50px; " x="36.471252" y="0">0</tspan>
<tspan style="font-size: 12.50px; " x="42.722752" y="0">5</tspan>
<tspan style="font-size: 12.50px; " x="48.974251" y="0">)</tspan>
</text>
</g>
</g>
</svg> to the other treatment groups (3 and 4), and a similar mean value when compared with negative control (group 1).</table>

BioMed Research International

fig5

Figure 5

Figure 5: Prevention of Chronic Experimental Colitis Induced by Dextran Sulphate Sodium (DSS) in Mice Treated with FR91 